CSF1R and multiple system atrophy: However, in a MSA mice model, the depletion of myeloid cells using CSF1R inhibitor (PLX5622) surprisingly improved overall survival with a delayed onset and reduced inflammation, but animals presented severe impaired motor functions, synaptic signaling, and neuronal circuitries (106).